Results

Total Results: 445 records

Showing results for "breast cancer".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-options-summarizing.ppt
    June 01, 2012 - For other disease states that are not directly observable, such as the presence of early stage breastcancer, the true status of the individual tested is determined by a separate reference method. … In the example of early stage breast cancer, the gold standard could be the tissue that is removed during
  2. effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-options-summarizing.ppt
    June 01, 2012 - For other disease states that are not directly observable, such as the presence of early stage breastcancer, the true status of the individual tested is determined by a separate reference method. … In the example of early stage breast cancer, the gold standard could be the tissue that is removed during
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
    September 08, 2011 - predictive studies will be assessed based on an approach applied to a systematic review of HER2 testing for breastcancer and other solid tumors (Table 1) 16 . … HER2 Testing to Manage Patients With Breast Cancer or Other Solid Tumors.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
    December 01, 2017 - low strength of evidence that, if prescribed to women with fibroids for other conditions such as breastcancer prophylaxis, raloxifene will not cause significant growth of existing fibroids or exacerbate
  5. effectivehealthcare.ahrq.gov/health-topics/health-screening
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_disposition-comments.pdf
    October 23, 2014 - lacking for imaging tests, there are a number of cases where this is not the case (mammography for breastcancer screening, CT for lung cancer screening, imaging in patients with LBP, etc.). … lacking for imaging tests, there are a number of cases where this is not the case (mammography for breastcancer screening, CT for lung cancer screening, imaging in patients with low back pain, etc.).
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/instrumental-variable-methods_research.pdf
    April 01, 2010 - variables in the presence of heterogeneity and self-selection: an application to treatments of breastcancer patients. … Was breast conserving surgery underutilized for early stage breast cancer?
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/healthcare-system-draft-technical-brief.pdf
    February 01, 2023 - Does a Multidisciplinary Approach to Invasive Breast Cancer Care Improve Time to Treatment and Patient
  9. effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables1.xls
    August 25, 2011 - OT.1 Table 1. Proportion of Beneficiaries With and Without Cancer Diagnosis Prior to First Biologics Order Among Beneficiaries Satisfying a Period of of Continuous AB FFS Enrollment Prior to First Relevant Claim by Class of Drug, Active Ingredient, and Period of Continuous Enrollment , 2006-2009 Note: A dash …
  10. effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables.xls
    August 25, 2011 - OT.1 Table 1. Proportion of Beneficiaries With and Without Cancer Diagnosis Prior to First Biologics Order Among Beneficiaries Satisfying a Period of of Continuous AB FFS Enrollment Prior to First Relevant Claim by Class of Drug, Active Ingredient, and Period of Continuous Enrollment , 2006-2009 Note: A dash …
  11. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - conditions included multiple postmarketing studies to evaluate cardiovascular outcomes, potential risks of breastcancer, a form of thyroid cancer called medullary thyroid carcinoma, and liraglutide use in pediatric … years duration to identify any increase in MTC incidence; and an evaluation of the potential risk of breastcancer in ongoing clinical trials. … Studies better defining the potential long-term risks (breast cancer and cardiovascular risks) need
  12. effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
    January 01, 2015 - One patient on dapagliflozin 10 mg was diagnosed with breast cancer within the first year of enrollment.Page … One patient on dapagliflozin 10 mg was diagnosed with breast cancer within the first year of enrollment
  13. effectivehealthcare.ahrq.gov/products/instrumental-variable-methods/research
    May 14, 2010 - instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breastcancer patients. … Was breast conserving surgery underutilized for early stage breast cancer?
  14. effectivehealthcare.ahrq.gov/products/psoriasis-chronic/research-protocol
    September 27, 2011 - prophylaxis and treatment of meningeal leukemia; used alone or in combination therapy in the treatment of breastcancer, epidermoid carcinomas of the head and neck, advanced mycosis fungoides, lung cancer, and advanced-stage
  15. effectivehealthcare.ahrq.gov/health-topics/breastfeeding/
  16. effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
    January 01, 2012 - 59 Abstract This chapter discusses considerations for comparator selection in observational comparative effectiveness research (CER). Comparison groups should reflect clinically meaningful choices in real world practice and be chosen based on the study question being addressed. Recognizing the implications and pote…
  17. Slide 1 (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/marketing_evidence_evans.ppt
    September 13, 2006 - efforts to change consumer behavior, primarily through risk communication Good examples from prostate & breastcancer screening (McCormack et al., in press) Very little published research on social marketing to
  18. effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
    August 01, 2013 - Additional tags may be added to a lead to denote subcategories within a broad priority area (e.g., breastcancer, peripheral artery disease, type I diabetes).
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments Rapid Evidence Product Adverse Events Associated With COVID-19 Pharmaceutical Treatments Background and Purpose The purpose of this rapid review is to determine if COVID treatments authorized for emergency use…
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
    January 10, 2012 - prophylaxis and treatment of meningeal leukemia; used alone or in combination therapy in the treatment of breastcancer, epidermoidcarcinomas of the head and neck, advanced mycosis fungoides, lung cancer, and

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: